Whalegun
Home

Daniel S. Lorrain, Chief Scientific Officer: Contineum Therapeutics CTNM Sell · Filed 24/11/20

Trade details

Type
Insider sale
Amount
$99,709.67
Shares · price
6,091 sh · $16.37 a share
Held after
169,671 sh
Stock
Contineum Therapeutics CTNM
Person
Daniel S. LorrainChief Scientific Officer
Trade date
24/11/18
Filed
24/11/20
Days to filing
2 days

Sold 3.5% of holdings

Share of holding sold
3.5%

Contineum Therapeutics trades, last 26 weeks

What else happened in Contineum Therapeutics around then

Filed or reported within 30 days of the trade day · 24/10/19~24/12/18

Daniel S. Lorrain's recent trades

  • Daniel S. Lorrain

    Planned sale10b5-1 planContineum Therapeutics

    $154.6K

    Filed 09/01

  • Daniel S. Lorrain

    Planned sale10b5-1 planContineum Therapeutics

    $147.5K

    Filed 08/03

  • Daniel S. Lorrain

    Planned sale10b5-1 planContineum Therapeutics

    $156K

    Filed 07/01

  • Daniel S. Lorrain

    Planned sale10b5-1 planContineum Therapeutics

    $432.4K

    Filed 06/30

  • Daniel S. Lorrain

    Sell10b5-1 planContineum Therapeutics

    $54.9K

    Filed 06/01